Skip to main content

Table 2 Characteristics of hybrid surgery and multilevel ACDF cohorts

From: A real-world analysis of hybrid CDA and ACDF compared to multilevel ACDF

Ā 

Hybrid Surgery

ALL Patients

mACDF

ALL Patients

Standardized Difference 2

N=

430

N=

2,136

N/Mean

%/SD

N/Mean

%/SD

Age (Mean, SD)

48.8

9.2

49.2

9.2

4.0

Ā Median

49.0

Ā 

49.0

Ā Ā 

Ā Range

24

80

18

92

Ā 

Sex (N, %)

Ā Ā Ā Ā Ā 

Ā Male

211

49.1%

1,047

49.0%

0.1

Ā Female

219

50.9%

1,089

51.0%

0.1

Geographic region (N, %)

Ā Ā Ā Ā Ā 

Ā Northeast

71

16.5%

338

15.8%

1.9

Ā North Central

81

18.8%

396

18.5%

0.8

Ā South

197

45.8%

993

46.5%

1.4

Ā West

76

17.7%

393

18.4%

1.9

Ā Unknown

5

1.2%

16

0.7%

4.3

Population Density (N, %)

Ā Ā Ā Ā Ā 

Ā Urban

392

91.2%

1,773

83.0%

24.5

Ā Rural

33

7.7%

348

16.3%

26.8

Ā Unknown

5

1.2%

15

0.7%

4.8

Insurance plan type 1 (N, %)

Ā Ā Ā Ā Ā 

Ā Comprehensive/indemnity

13

3.0%

67

3.1%

0.7

Ā EPO/PPO

262

60.9%

1,258

58.9%

4.2

Ā POS/POS with capitation

38

8.8%

202

9.5%

2.1

Ā HMO

43

10.0%

200

9.4%

2.2

Ā CDHP/HDHP

68

15.8%

368

17.2%

3.8

Ā Other/Unknown

6

1.4%

41

1.9%

4.1

Index year (N, %)

Ā Ā Ā Ā Ā 

Ā 2014

66

15.3%

312

14.6%

2.1

Ā 2015

84

19.5%

446

20.9%

3.4

Ā 2016

60

14.0%

308

14.4%

1.3

Ā 2017

87

20.2%

462

21.6%

3.4

Ā 2018

73

17.0%

345

16.2%

2.2

Ā 2019

59

13.7%

254

11.9%

5.5

Ā 2020

1

0.2%

9

0.4%

3.3

Charlson Comorbidity Index (CCI) (Mean, SD)

0.5

0.9

0.4

0.9

1.7

Ā Range

0

8

0

8

Ā 

Spinal Disease Conditions (N, %)

Ā Ā Ā Ā Ā 

Ā Cervical spondylosis

229

53.3%

1,211

56.7%

6.9

Ā Degenerative disc disease

182

42.3%

866

40.5%

3.6

Ā Other cervical disc disorders

263

61.2%

1,006

47.1%

28.5

Other Comorbid Conditions (N, %)

Ā Ā Ā Ā Ā 

Ā Osteoporosis

4

0.9%

23

1.1%

1.5

Ā Radiculopathy or myelopathy

263

61.2%

1,261

59.0%

4.3

Ā Pain conditions

337

78.4%

1,645

77.0%

3.3

Ā Ā Neck

307

71.4%

1,492

69.9%

3.4

Ā Ā Shoulder

98

22.8%

518

24.3%

3.4

Ā Ā Arm

64

14.9%

313

14.7%

0.6

Duration of Follow-up (Mean, SD)

687.3

519.0

718.4

563.7

5.7

Ā Range

2

2287

1

2368

Ā 
  1. 1 EPO: Exclusive provider organization; PPO: Preferred provider organization; HMO: Health maintenance organization; POS: Point of service; CDHP: Consumer-driven health plan; HDHP: High deductible health plan
  2. 2 Standardized difference is the measure of effect size used to assess balance between cohorts during propensity score matching; valuesā€‰>ā€‰10 indicate imbalance for the specific covariate of interest
  3. mACDF: multilevel anterior discectomy and fusion